Spironolactone: A Glucocorticoid Agonist or Antagonist?
Authors:
- Thomas J. CampenTCThomas J. Campen
- Darrell D. FanestilDFDarrell D. Fanestil
- 1 January 1982
- journal article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 4 (9-10) , 1627-1636
Abstract
Spironolactone displaces 3H-dexamethasone from HTC cell nuclei and inhibits the induction of tyrosine aminotransferase (TAT) activity by dexamethasone in HTC cells. Spironolactone alone fails to increase TAT activity in HTC cells or in the liver of adrenalectomized rats. These actions indicate that spironolactone lacks glucocorticoid agonist activity but can be an antagonistic to the actions of glucocorticoid as well as mineralocorticoid steroid hormones.Keywords
This publication has 3 references indexed in Scilit:
- Competitive inhibition of dexamethasone binding to the glucocorticoid receptor in HTC cells by tryptophan methyl esterThe Journal of Steroid Biochemistry and Molecular Biology, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Assay of tyrosine transaminase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenzaldehydeAnalytical Biochemistry, 1966